Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1Lymphoid 1

Conditions

Multiple Myeloma 52Neoplasms, Plasma Cell 5Neoplasms 4Lymphoma 4Waldenstrom Macroglobulinemia 3Recurrence 3Hematologic Neoplasms 3Prostatic Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Breast Neoplasms 2Bone Neoplasms 2Back Pain 2Venous Thromboembolism 1Stomatitis 1Skin Neoplasms 1Renal Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumococcal 1Pneumococcal Infections 1Peripheral Nervous System Diseases 1Pain 1Osteoporosis 1Osteonecrosis 1Osteolysis 1Myeloproliferative Disorders 1Multiple Sclerosis 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1

Interventions

Kyphoplasty 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Back Pain × Plasma cell × Clear all
NCT00211211 2017-12-08

FREE Study - Fracture Reduction Evaluation

Medtronic Spinal and Biologics

Phase 4 Completed
300 enrolled
Plasma cellSarcoma

Back Pain, Bone Diseases, Metabolic, Bone Neoplasms, Multiple Myeloma, Osteoporosis

NCT01410929 2017-01-20

MM

Merit Medical Systems, Inc.

Phase 4 Withdrawn
Plasma cell

Back Pain, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡